Evidence map›Paper›PMID 25475876›Full record

ReviewHippocampus2015

Neuromodulatory signaling in hippocampus-dependent memory retrieval.

Steven A Thomas

Abstract readReview
In one paragraph

Review in Hippocampus, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dopamine D3 Receptor Modulates Akt/mTOR and ERKInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval.Current topics in behavioral neurosciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The authors respond to "Fentanyl patch probably not related to amnesia in case".CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  14. Senescent neurophysiology: CaNeurobiology of learning and memory · 2019
    Review
  15. Article
  16. Procognitive impact of ciproxifan (a histaminergic HCNS neuroscience & therapeutics · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Steven A ThomasDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

Molecular mechanisms of memrory retrievalR01MH063352 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI THOMAS, STEVEN A · 2002 to 2011
$3.2M
Molecular Mechanisms of the Stress ResponseR01MH100319 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI THOMAS, STEVEN A · 2014 to 2017
$1.6M
NIMH NIH HHS 1R01MH100319NIMH NIH HHS 5R01MH063352NIMH NIH HHS R01 MH063352NIMH NIH HHS R01 MH100319
6 · The paper itself

Abstract

Considerable advances have been made toward understanding the molecular signaling events that underlie memory acquisition and consolidation. In contrast, less is known about memory retrieval, despite its necessity for utilizing learned information. This review focuses on neuromodulatory and intracellular signaling events that underlie memory retrieval mediated by the hippocampus, for which the most information is currently available. Among neuromodulators, adrenergic signaling is required for the retrieval of various types of hippocampus-dependent memory. Although they contribute to acquisition and/or consolidation, cholinergic and dopaminergic signaling are generally not required for retrieval. Interestingly, while not required for retrieval, serotonergic and opioid signaling may actually constrain memory retrieval. Roles for histamine and non-opioid neuropeptides are currently unclear but possible. A critical effector of adrenergic signaling in retrieval is reduction of the slow afterhyperpolarization mediated by β1 receptors, cyclic AMP, protein kinase A, Epac, and possibly ERK. In contrast, stress and glucocorticoids impair retrieval by decreasing cyclic AMP, mediated in part by the activation of β2 -adrenergic receptors. Clinically, alterations in neuromodulatory signaling and in memory retrieval occur in Alzheimer's disease, Down syndrome, depression, and post-traumatic stress disorder, and recent evidence has begun to link changes in neuromodulatory signaling with effects on memory retrieval.

Indexed as

AnimalsGlucocorticoidsHippocampusHumansMental RecallNeurotransmitter AgentsSignal TransductionGlucocorticoidsNeurotransmitter AgentsadrenergicCA1cyclic AMPglucocorticoidslow afterhyperpolarization

Identifiers

PMID25475876
PMCPMC9484472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.